首页> 外文OA文献 >Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients

【2h】

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients

机译：用于非合作Covid-19患者的洛诺瓦尔和Ritonavir悬浮液的数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
D. Zanon; U.M. Musazzi; A. Manca; A. De Nicolò; A. DAvolio; F. Cilurzo; N. Maximova; C. Tomasello; E. Clementi; P. Minghetti;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients [J] . D. Zanon, U.M. Musazzi, A. Manca, Data in Brief . 2020,第2期

机译：用于非合作Covid-19患者的洛诺瓦尔和Ritonavir悬浮液的数据
2. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial [J] . Justin T. Denholm, Joshua Davis, David Paterson, Trials . 2020,第1期

机译：澳大利亚Covid-19试验（ASCOT）评估住院治疗的SARS-COV-2感染（Covid-19）的临床结果与Lopinavir / Ritonavir和/或羟氯喹与护理标准进行治疗：研究方案的结构化概述对于随机对照试验
3. Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data [J] . Mark Nelson, Pierre-Marie Girard, Ralph DeMasi, Journal of Antimicrobial Chemotherapy . 2010,第7期

机译：与lopinavir / ritonavir相比，对于未接受过治疗且感染HIV的患者，与darinavir / ritonavir的亚最佳依从性对疗效的影响微乎其微：96周ARTEMIS数据
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost-Effectiveness Analysis of Nevirapine vs. Ritonavir-Boosted Lopinavir in HIV-infected Children With Peripartum Nevirapine Exposure In Resource-Constrained Areas From Payer's Perspective. [D] . Godwin, Onyeka Peter. 2014

机译：从付款人的角度来看，在资源受限地区感染了围产期尼维拉平的HIV感染儿童中，奈韦拉平vs.利托那韦促进洛匹那韦的成本-效果分析。
6. Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients [O] . D. Zanon, U.M. Musazzi, A. Manca, 2020

机译：用于非合作Covid-19患者的洛诺瓦尔和Ritonavir悬浮液的数据
7. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 [O] . Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, 2021

机译：Lopinavir / Ritonavir，Lopinavir / Ritonavir Plus IFN-β-1A和羟基氯喹在住院治疗患者中的开放标签随机对照试验，Covid-19患者

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients

著录项

引文网络

相似文献

相关主题

期刊订阅